
Tirzepatide
Investigational GIP / GLP-1 Receptor Agonist
Overview
Tirzepatide is a synthetic peptide studied for dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Current research examines receptor signaling, glucose homeostasis, metabolic pathways, energy regulation, appetite-related signaling, and associated physiological mechanisms.
Research Focus
GIP and GLP-1 receptor signaling
Glucose homeostasis and metabolic pathways
Appetite and satiety signaling
Energy-balance mechanisms
Metabolic and body-composition research
Product Specifications
Form: Lyophilized peptide
In-Stock Strengths: 10 mg, 20 mg
Special-Order Strengths: 5 mg, 15 mg, 30 mg, 40 mg, 50 mg, 60 mg, 80 mg, 100 mg, 120 mg
Special Orders
Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.
Storage
Store refrigerated at 2–8°C, unless otherwise specified.
Research Use Only
For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.
